Long-term outcome after interferon therapy in elderly patients with chronic hepatitis C.
作者： Yasuji Arase , Kenji Ikeda , Fumitaka Suzuki , Yoshiyuki Suzuki , Satoshi Saitoh
DOI: 10.1159/000096308
关键词: Hepatocellular carcinoma 、 Pharmacotherapy 、 Clinical trial 、 Survival analysis 、 Internal medicine 、 Interferon 、 Cause of death 、 Medicine 、 Incidence (epidemiology) 、 Immunology 、 Hepatitis C
摘要: Objective: The purpose of this study was to elucidate the long-term outcome after interferon (IFN) therapy in chronic hepatitis C elderly patients. Methods: We st
sci-hub.se 参考文章(18)
F Imazeki, Favorable prognosis of chronic hepatitis C after interferon therapy by long-term cohort study Hepatology. ,vol. 38, pp. 493- 502 ,(2003) , 10.1053/JHEP.2003.50329
Takeshi Okanoue, Yoshito Itoh, Masahito Minami, Shinichi Sakamoto, Kohichiro Yasui, Masafumi Sakamoto, Kenichi Nishioji, Yoshiki Murakami, Kei Kashima, Interferon therapy lowers the rate of progression to hepatocellular carcinoma in chronic hepatitis C but not significantly in an advanced stage: a retrospective study in 1148 patients Journal of Hepatology. ,vol. 30, pp. 653- 659 ,(1999) , 10.1016/S0168-8278(99)80196-2
Lawrence Serfaty, Hugues Aumaître, Olivier Chazouillères, Anne-Marie Bonnand, Olivier Rosmorduc, Renée E. Poupon, Raoul Poupon, Determinants of outcome of compensated hepatitis C virus-related cirrhosis Hepatology. ,vol. 27, pp. 1435- 1440 ,(1998) , 10.1002/HEP.510270535
Hideo Tanaka, Hideaki Tsukuma, Hajime Yamano, Akira Oshima, Hirotoshi Shibata, None, Prospective study on the risk of hepatocellular carcinoma among hepatitis C virus-positive blood donors focusing on demographic factors, alanine aminotransferase level at donation and interaction with hepatitis B virus International Journal of Cancer. ,vol. 112, pp. 1075- 1080 ,(2004) , 10.1002/IJC.20507
Robert G. Knodell, Kamal G. Ishak, William C. Black, Thomas S. Chen, Robert Craig, Neil Kaplowitz, Thomas W. Kiernan, Jerome Wollman, Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis Hepatology. ,vol. 1, pp. 431- 435 ,(1981) , 10.1002/HEP.1840010511
Geoffrey Dusheiko, Hemda Schmilovitz-Weiss, David Brown, Fiona McOmish, Pong-Lee Yap, Sheila Sherlock, Neil McIntyre, Peter Simmonds, Hepatitis C Virus Genotypes: An Investigation of Type-specific Differences in Geographic Origin and Disease Hepatology. ,vol. 19, pp. 13- 18 ,(1994) , 10.1002/HEP.1840190104
Rosa Giovanna Simonetti, Hepatitis C Virus Infection as a Risk Factor for Hepatocellular Carcinoma in Patients with Cirrhosis Annals of Internal Medicine. ,vol. 116, pp. 97- 102 ,(1992) , 10.7326/0003-4819-116-2-97
Alain Doglio, Catherine Laffont, François X. Caroli-Bosc, Pascale Rochet, J.-Claude Lefebvre, Second generation of the automated Cobas Amplicor HCV assay improves sensitivity of hepatitis C virus RNA detection and yields results that are more clinically relevant. Journal of Clinical Microbiology. ,vol. 37, pp. 1567- 1569 ,(1999) , 10.1128/JCM.37.5.1567-1569.1999
Yasuharu Imai, Relation of Interferon Therapy and Hepatocellular Carcinoma in Patients with Chronic Hepatitis C Annals of Internal Medicine. ,vol. 129, pp. 94- 99 ,(1998) , 10.7326/0003-4819-129-2-199807150-00005
Dp Harrington, A class of rank test procedures for censored survival data Biomedica. ,vol. 62, pp. 553- 566 ,(1982)